We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Combination Biologic-Device Product Awarded FDA Breakthrough Device Status
Combination Biologic-Device Product Awarded FDA Breakthrough Device Status
The FDA has designated BioCardia’s CardiAMP Cell Therapy System for heart failure a breakthrough device, making it the first combination cardiac cell therapy and device to receive this status.